Thrombophilia in pregnancy: A systematic review

British Journal of Haematology

Volumn 132, Issue 2, 2006, Pages 171-196

  Robertson, L ^a   Wu, O ^a   Langhorne, P ^a   Twaddle, S ^b   Clark, P ^c   Lowe, G D O ^a,b   Walker, I D ^a   Greaves, M ^d   Brenkel, I ^e   Regan, L ^f   Greer, I A ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b Scottish Intercollegiate Guidelines Network   (United Kingdom)

^c NINEWELLS HOSPITAL   (United Kingdom)

^d UNIVERSITY OF ABERDEEN   (United Kingdom)

^e NHS FIFE   (United Kingdom)

^f IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Pregnancy outcomes; Systematic review; Thrombophilia

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO; WARFARIN;

ABORTION; BLEEDING; CALCULATION; CLINICAL TRIAL; COCHRANE LIBRARY; DATA BASE; DISEASE ASSOCIATION; EPISTAXIS; GINGIVA BLEEDING; HEMATURIA; HUMAN; INJECTION SITE BLEEDING; INTRAUTERINE GROWTH RETARDATION; LITERATURE; LOW DRUG DOSE; MEDLINE; META ANALYSIS; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROPHYLAXIS; QUALITY CONTROL; REVIEW; SOLUTIO PLACENTAE; SYSTEMATIC REVIEW; THROMBOPHILIA; VENOUS THROMBOEMBOLISM; FEMALE; FETUS DEATH; VEIN THROMBOSIS;

FEMALE; FETAL DEATH; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY OUTCOME; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 32544441595     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05847.x     Document Type: Review

References (100)

1. Agorastos T. Karavida A. Lambropoulos A. Constantinidis T. Tzitzimikas S. Chrisafi S. 2002 Factor V Leiden and prothrombin G20210A mutations in pregnancies with adverse outcome Journal of Maternal-Fetal and Neonatal Medicine 12 267 273
2. Alfirevic Z. Mousa H.A. Martlew V. Briscoe L. Perez-Casal M. Toh C.H. 2001 Postnatal screening for thrombophilia in women with severe pregnancy complications Obstetrics and Gynecology 97 5:Pt 1 0t-9
3. Alfirevic Z. Roberts D. Martlew V. 2002 How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review European Journal of Obstetric and Gynaecological Reproductive Biology 101 6 14
4. Allen J.Y. Tapia-Santiago C. Kutteh W.H. 1996 Antiphospholipid antibodies in patients with preeclampsia American Journal of Reproductive Immunology (Copenhagen) 36 81 85
5. Alonso A. Soto I. Urgelles M.F. Corte J.R. Rodriguez M.J. Pinto C.R. 2002 Acquired and inherited thrombophilia in women with unexplained fetal losses American Journal of Obstetrics and Gynecology 187 337 342
6. Balasch J. Reverter J.C. Fabregues F. Tassies D. Rafel M. Creus M. 1997 First-trimester repeated abortion is not associated with activated protein C resistance Human Reproduction 12 1094 1097
7. Bare S.N. Poka R. Balogh I. Ajzner E. 2000 Factor V Leiden as a risk factor for miscarriage and reduced fertility Australian and New Zealand Journal of Obstetrics and Gynecology 40 186 190
8. Benedetto C. Marozio L. Salton L. Maula V. Chieppa G. Massobrio M. 2002 Factor V Leiden and factor II G20210A in preeclampsia and HELLP syndrome Acta Obstetricia et Gynecologica Scandinavia 81 1095 1100
9. Bocciolone L. Meroni P. Parazzini F. Tincani A. Radici E. Tarantini M. 1994 Antiphospholipid antibodies and risk of intrauterine late fetal death Acta Obstetricia et Gynecologica Scandinavica 73 389 392
10. Brenner B. Hoffman R. Carp H. Dulitsky M. Younis J. for the LIVE-ENOX investigators 2005 Efficacy and safety of two doses of enoxaparin in women with thrombophila and recurrent pregnancy losses: the LIVE-ENOX study Journal of Thrombosis and Haemostasis 3 227 229
11. Carp H. Salomon O. Seidman D. Dardik R. Rosenberg N. Inbal A. 2002 Prevalence of genetic markers for thrombophilia in recurrent pregnancy loss Human Reproduction 17 1633 1637
12. Chakrabarti S. Bhunia C. Bhattacharya D.K. 1999 The prevalence of antiphospholipid antibodies in cases of recurrent pregnancy loss The Journal of the Association of Physicians of India 47 496 498
13. Currie L. Peek M. McNiven M. Prosser I. Mansour J. Ridgway D. 2002 Is there an increased maternal-infant prevalence of Factor V Leiden in association with severe pre-eclampsia British Journal of Obstetrics and Gynaecology 109, 191 196
14. D'Elia A.V. Driul L. Giacomello R. Colaone R. Fabbro D. Di Leonardo C. 2002 Frequency of factor V, prothrombin and methylenetetrahydrofolate reductase gene variants in preeclampsia Gynecological and Obstetrical Investigation 53 84 87
15. Das I. Vasishta K. Dash S. 1991 Study of lupus anticoagulant in pregnant women with recurrent abortion Australian and New Zealand Journal of Obstetrics and Gynecology 31 323 326
16. De Carolis S. Caruso A. Ferrazzani S. Carducci B. De Santis L. Mancuso S. 1994 Poor pregnancy outcome and anticardiolipin antibodies Fetal Diagnostic Therapy 9 296 299
17. Department of Health Welsh Office Scottish Home and Health Department and Department of Health and Social Services Northern Ireland 1998 Confidential Enquiries into Maternal Deaths in the United Kingdom 1994-1997 TSO London
18. DerSimonian R. Laird N. 1986 Meta-analysis in clinical trials Controlled Clinical Trials 7 177 188
19. Dilley A. Austin H. El Jamil M. Hooper W.C. Barnhart E. Evatt B.L. 2000 Genetic factors associated with thrombosis in pregnancy in a United States population American Journal of Obstetrics and Gynecology 183 1271 1277
20. Dizon-Townson D.S. Nelson L.M. Easton K. Ward K. 1996 The factor V Leiden mutation may predispose women to severe preeclampsia American Journal of Obstetrics and Gynecology 175 Pt 1 t-5
21. Dreyfus M. Hedelin G. Kutnahorsky R. Lehmann M. Viville B. Langer B. 2001 Antiphospholipid antibodies and preeclampsia: a case-control study Obstetrics and Gynecology 97 29 34
22. Egger M. Juni P. Bartlett C. Holenstein F. Sterne J. 2003 How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study Health Technology Assessment 7 1 76
23. Empson M. Lassere M. Craig J.C. Scott J.R. 2002 Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials Obstetrics and Gynecology 99 135 144
24. Farquharson R.G. Quenby S. Greaves M. 2002 Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment Obstetrics and Gynecology 100 408 413
25. Fatini C. Gensini F. Battaglini B. Prisco D. Cellai A.P. Fedi S. 2000 Angiotensin-converting enzyme DD genotype, angiotensin type 1 receptor CC genotype, and hyperhomocysteinemia increase first-trimester fetal-loss susceptibility Blood Coagulation and Fibrinolysis 11 657 662
26. Finan R.R. Tamim H. Ameen G. Sharida H.E. Rashid M. Almawi W.Y. 2002 Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population American Journal of Haematology 71 300 305
27. Foka Z.J. Lambropoulos A.F. Saravelos H. Karas G.B. Karavida A. Agorastos T. 2000 Factor V Leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages Human Reproduction 15 458 462
28. Franco R.F. Araujo A.G. Guerreiro J.F. Elion J. Zago M.A. 1998 Analysis of the 677 CT mutation of the methylenetetrahydrofolate reductase gene in different ethnic groups Thrombosis and Haemostasis 77 466 471
29. Franklin R.D. Kutteh W.H. 2002 Antiphospholipid antibodies (APA) and recurrent pregnancy loss: treating a unique APA positive population Human Reproduction 17 2981 2985
30. Gates S. 2000 Thromboembolic disease in pregnancy Current Opinion in Obstetrics and Gynecology 12 117 122
31. Gerhardt A. Scharf R.E. Beckmann M.W. Struve S. Bender H.G. Pillny M. 2000 Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium New England Journal of Medicine 342 374 380
32. Ghee C.B. Burrows R.F. 2002 Prothrombin G20210A mutation is not associated with recurrent miscarriages Australian and New Zealand Journal of Obstetrics and Gynecology 42 167 169
33. Goddijn-Wessel T.A.W. Wouters M.G.A.J. Molen E.F. Spuijbroek M.D.E.H. Steegers-Theunissen R.P.M. Blom H.J. 1996 Hyperhomocysteinemia: a risk factor for placental abruption or infarction European Journal of Obstetrics, Gynecology and Reproductive Biology 66 23 29
34. Gompel A. Levy D.P. Conard J. 2002 Ovarian hyperstimulation and thrombosis In: Women's Issues Thrombosis and Haemostasis pp 143 150 Martin Dunitz London
35. Grandone E. Margaglione M. Colaizzo D. Ad'Addedda M. Cappucci G. Vecchione G. 1997a Factor V Leiden is associated with repeated and recurrent unexplained fetal losses Thrombosis and Haemostasis 77 822 824
36. Grandone E. Margaglione M. Colaizzo D. Cappucci G. Paladini D. Martinelli P. 1997b Factor V Leiden, C > T MTHFR polymorphism and genetic susceptibility to preeclampsia Thrombosis and Haemostasis 77 1052 1054
37. Grandone E. Margaglione M. Colaizzo D. D'Andrea G. Cappucci G. Brancaccio V. 1998 Genetic susceptibility to pregnancy-related venous thromboembolism: roles of factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations American Journal of Obstetrics and Gynecology 179 1324 1328
38. Grandone E. Margaglione M. Colaizzo D. Cappucci G. Scianname N. Montanaro S. 1999 Prothrombotic genetic risk factors and the occurrence of gestational hypertension with or without proteinuria Thrombosis and Haemostasis 81 349 352
39. Greer I.A. 2003 Thrombophilia: implications for pregnancy outcome Thrombosis Research 2152 1 9
40. Gris J.C. Quere I. Monpeyroux F. Mercier E. Ripart-Neveu S. Tailland M.L. 1999 Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent - the Nimes Obstetricians and Haematologists Study 5 (NOHA5) Thrombosis and Haemostasis 81 891 899
41. Gris J.C. Mercier E. Quere I. Lavigne-Lissalde G. Cochery-Nouvellon E. Hoffet M. 2004 Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder Blood 103 3695 3699
42. de Groot C.J. Bloemenkamp K.W. Duvekot E.J. Helmerhorst F.M. Bertina R.M. Van Der M.F. 1999 Preeclampsia and genetic risk factors for thrombosis: a case-control study American Journal of Obstetrics and Gynecology 181 975 980
43. Hatzis T. Cardamakis E. Drivalas E. Makatsoris K. Bevan D. Pantos C. 1999 Increased resistance to activated protein C and factor V Leiden in recurrent abortions. Review of other hypercoagulability factors European Journal of Contraceptive and Reproductive Health Care 4 135 144
44. Higashino M. Takakuwa K. Arakawa M. Tamura M. Yasuda M. Tanaka K. 1998 Anti-cardiolipin antibody and anti-cardiolipin beta-2-glycoprotein I antibody in patients with recurrent fetal miscarriage Journal of Perinatal Medicine 26 384 389
45. Higgins J. Thompson S. Deeks J. Altman D. 2003 Measuring inconsistency in meta-analyses British Medical Journal 327 557 560
46. Holmes Z.R. Regan L. Chilcott I. Cohen H. 1999 The C677T MTHFR gene mutation is not predictive of risk for recurrent fetal loss British Journal of Haematology 105 98 101
47. Infante-Rivard C. David M. Gauthier R. Rivard G.E. 1991 Lupus anticoagulants, anticardiolipin antibodies, and fetal loss. A case-control study New England Journal of Medicine 325 1063 106
48. Infante-Rivard C. Rivard G.E. Yotov W.V. Genin E. Guiguet M. Weinberg C. 2002 Absence of association of thrombophilia polymorphisms with intrauterine growth restriction New England Journal of Medicine 347 19 25
49. Kim Y.J. Williamson R.A. Murray J.C. Andrews J. Pietscher J.J. Peraud P.J. 2001 Gentic susceptibility to preeclampsia: role of cytosine-to-thymine substitution at nucleotide 677 of the gene for mtheylenetetrahydrofolate reductase, 68-base pair insertion at nucleotide 844 of the gene for cystathionine B-synthase, and factor V Leiden mutation American Journal of Obstetrics and Gynecology 184 1211 1217
50. Kupferminc M.J. Eldor A. Steinman N. Many A. Bar-Am A. Jaffa A. 1999 Increased frequency of genetic thrombophilia in women with complications of pregnancy New England Journal of Medicine 340 9 13
51. Kupferminc M.J. Peri H. Zwang E. Yaron Y. Wolman I. Eldor A. 2000a High prevalence of the prothrombin gene mutation in women with intrauterine growth retardation, abruptio placentae and second trimester loss Acta Obstetricia et Gynecologica Scandinavia 79 963 967
52. Kupferminc M.J. Fait G. Many A. Gordon D. Eldor A. Lessing J.B. 2000b Severe preeclampsia and high frequency of genetic thrombophilic mutations Obstetrics and Gynecology 96 45 49
53. Kupferminc M.J. Many A. Bar-Am A. Lessing J.B. Ascher-Landsberg J. 2002 Mid-trimester severe intrauterine growth restriction is associated with a high prevalence of thrombophilia British Journal of Obstetrics and Gynaecology 109 1373 1376
54. Kutteh W.H. 1996 Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone American Journal of Obstetrics and Gynecology 174 1584 1589
55. Kutteh W.H. Ermel L.D. 1996 A clinical trial for the treatment of antiphospholipid antibody-associated recurrent pregnancy loss with lower dose heparin and aspirin American Journal of Reproductive Immunology 35 402 407
56. Lissak A. Sharon A. Fruchter O. Kassel A. Sanderovitz J. Abramovicic H. 1999 Polymorphism for mutation of cytosine to thymine at location 677 in the methylenetetrahydrofolate reductase gene is associated with recurrent early fetal loss American Journal of Obstetrics and Gynecology 181 126 130
57. Many A. Elad R. Yaron Y. Eldor A. Lessing J.B. Kupferminc M.J. 2002 Third-trimester unexplained intrauterine fetal death is associated with inherited thrombophilia Obstetrics and Gynecology 99 Pt 1 t-7
58. Martinelli I. Taioli E. Cetin I. Marinoni A. Gerosa S. Villa M.V. 2000 Mutations in coagulation factors in women with unexplained late fetal loss New England Journal of Medicine 343 1015 1018
59. Martinelli I. Legnani C. Bucciarelli P. Grandone E. De Stefano V. Mannucci P.M. 2001a Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia Thrombosis and Haemostasis 86 800 803
60. Martinelli P. Grandone E. Colaizzo D. Paladini D. Scianname N. Margaglione M. 2001b Familial thrombophilia and the occurrence of fetal growth restriction Haematologica 86 428 431
61. Martinelli I. De Stefano V. Taioli E. Paciaroni K. Rossi E. Mannucci P.M. 2002 Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium Thrombosis and Haemostasis 87 791 795
62. Meinardi J.R. Middeldorp S. de Kam P.J. Koopman M.M. van Pampus E.C. Hamulyak K. 1999 Increased risk for fetal loss in carriers of the factor V Leiden mutation Annals of Internal Medicine 130 736 739
63. Mello G. Parretti E. Martini E. Mecacci F. La Torre P. Cioni R. 1999 Usefulness of screening for congenital or acquired hemostatic abnormalities in women with previous complicated pregnancies Haemostasis 29 197 203
64. Morrison E.R. Miedzybrodzka Z.H. Campbell D.M. Haites N.E. Wilson B.J. Watson M.S. 2002 Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review Thrombosis and Haemostasis 87 779 785
65. Murphy R.P. Donoghue C. Nallen R.J. D'Mello M. Regan C. Whitehead A.S. 2000 Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylenetetrahydrofolate reductase polymorphisms in pregnancy Arteriosclerosis Thrombosis and Vascular Biology 20 266 270
66. Nagy B. Toth T. Rigo Jr. J. Karadi I. Romics L. Papp Z. 1998 Detection of factor V Leiden in severe pre-eclamptic Hungarian women Clinical Genetics 53 478 481
67. Nelen W.L.D.M. van der Molen E.F. Blom H.J. Heil S.G. Steegers E.A.P. Eskes T.K.A.B. 1997 Recurrent early pregnancy loss and genetic-related disturbances in folate and homocysteine metabolism British Journal of Hospital Medicine 58 511 513
68. NHS Centre for Review & Dissemination 2001 Undertaking Systematic Reviews of Research on Effectiveness CRD's Guidance for those Carrying Out or Commissioning Reviews 2nd edn University of York York
69. O'Shaughnessy K.M. Fu B. Ferraro F. Lewis I. Downing S. Morris N.H. 1999 Factor V Leiden and thermolabile methylenetetrahydrofolate reductase gene variants in an East Anglian preeclampsia cohort Hypertension 33 1338 1341
70. Ogasawara M. Aoki K. Matsuura E. Sasa H. Yagami Y. 1996 Anti beta2glycoprotein I antibodies and lupus anticoagulant in patients with recurrent pregnancy loss: prevalence and clinical significance Lupus 5 587 592
71. Ogunyemi D. Cuellar F. Ku W. Arkel Y. 2003 Association between inherited thrombophilias, antiphospholipid antibodies, and lipoprotein a levels and venous thromboembolism in pregnancy American Journal of Perinatalogy 1 17 24
72. Owen E.P. Human L. Carolissen A.A. Harley E.H. Odendaal H.J. 1997 Hyperhomocysteinemia - a risk factor for abruptio placentae Journal of Inherited Metabolic Disease 20 359 362
73. Pabinger I. Nemes L. Rintelen C. Koder S. Lechler E. Loreth R.M. 2000 Pregnancy-associated risk for venous thromboembolism and pregnancy outcome in women homozygous for factor V Leiden Hematology Journal 1 37 41
74. Pattison N.S. Chamley L.W. Birdsall M. Zanderigo A.M. Liddell H.S. McDougall J. 2000 Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial American Journal of Obstetrics Gynecology 183 1008 1012
75. Pauzner R. Dulitzki M. Langevitz P. Livneh A. Kenett R. Many A. 2001 Low molecular weight heparin and warfarin in the treatment of patients with antiphospholipid syndrome during pregnancy Thrombosis and Haemostasis 86 1379 1384
76. Pickering W. Marriott K. Regan L. 2001 G20210A prothrombin gene mutation: prevalence in a recurrent miscarriage population Clinical and Applied Thrombosis and Haemostasis 7 25 28
77. Pihusch R. Buchholz T. Lohse P. Rubsamen H. Rogenhofe N. Hasbargen U. 2001 Thrombophilic gene mutations and recurrent spontaneous abortion: prothrombin mutation increases the risk in the first trimester American Journal of Reproductive Immunology 46 124 131
78. Rai R. Cohen H. Dave M. Regan L. 1997 Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies) British Medical Journal 314 253 257
79. Rai R. Shlebak A. Cohen H. Backos M. Holmes Z. Marriott K. 2001 Factor V leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage Human Reproduction 16 961 965
80. Raijmakers M.T.M. Zusterzeel P.L.M. Steegers E.A.P. Peters W.H.M. 2001 Hyperhomocysteinaemia: a risk factor for pre-eclampsia? European Journal of Obstetrics, Gynaecology and Reproductive Biology 95 226 228
81. Raziel A. Kornberg Y. Friedler S. Schachter M. Sela B.A. Ron-El R. 2001 Hypercoagulable thrombophilic defects and hyperhomocysteinemia in patients with recurrent pregnancy loss American Journal of Reproductive Immunology (Copenhagen) 45 65 71
82. Reid W. Perry D.J. 2001 Internal jugular vein thrombosis following in-vitro fertilization in a woman with protein S deficiency and heterozygosity for the prothrombin 3′ UTR mutation, despite anticoagulation with heparin Blood Coaguation and Fibrinolysis 12 487 489
83. Rey E. Kahn S.R. David M. Shrier I. 2003 Thrombophilic disorders and fetal loss: a meta-analysis The Lancet 361 901 908
84. Reznikoff-Etievan M.F. Cayol V. Carbonne B. Robert A. Coulet F. Milliez J. 2001 Factor V Leiden and G20210A prothrombin mutations are risk factors for very early recurrent miscarriage British Journal of Obstetrics and Gynaecology 108 1251 1254
85. Rigo Jr. J. Nagy B. Fintor L. Tanyi J. Beke A. Karadi I. 2000 Maternal and neonatal outcome of preeclamptic pregnancies: the potential roles of factor V Leiden mutation and 5,10 methylenetetrahydrofolate reductase Hypertension in Pregnancy 19 163 172
86. Rosendaal F.R. Doggen C.J. Zivelin A. Arruda V.R. Aiach M. Siscovick D.S. 1998 Geographic distribution of the 20210 G to A prothrombin variant Thrombosis and Haemostasis 79 706 708
87. Rothbart H. Ohel G. Younis J. Lanir N. Brenner B. 1999 High prevalence of activated protein C resistance due to factor V leiden mutation in cases of intrauterine fetal death Journal of Maternal and Fetal Medicine 8 228 230
88. Schjetlein R. Haugen G. Moe N. Husby H. Wisloff F. 1998 Preeclampsia and fetal growth retardation: is there an association with antiphospholipid antibodies Hypertension in Pregnancy 17 81 92
89. Scottish Obstetric Guidelines and Audit Project 1998 The Management of Postaprtum Haemorrhage: A Clinical Practice Guideline for Professionals Involved in Maternity Care in Scotland Scottish Programme for Clinical Effectiveness in Reproductive Health publication number 6. WWW document. URL.
90. Tal J. Schliamser L.M. Leibovitz Z. Ohel G. Attias D. 1999 A possible role for activated protein C resistance in patients with first and second trimester pregnancy failure Human Reproduction 14 1624 1627
91. Tormene D. Simioni P. Prandoni P. Luni S. Innella B. Sabbion P. 1999 The risk of fetal loss in family members of probands with factor V Leiden mutation Thrombosis and Haemostasis 82 1237 1239
92. Tormene D. Simioni P. Prandoni P. Luni S. Zerbinati P. Sartor D. 2001 Factor V Leiden mutation and the risk of venous thromboembolism in pregnant women Haematologica 86 1305 1309
93. Van Pampus M.G. Dekker G.A. Wolf H. Huijgens P.C. Koopman M.M.W. Von Blomberg B.M.E. 1999 High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia American Journal of Obstetrics and Gynecology 180 1146 1150
94. Walker I.D. 2000a Thrombophilia in pregnancy Journal of Clinical Pathology 53 573 580
95. Walker J.J. 2000b Pre-eclampsia The Lancet 356 1260 1265
96. Walker M.C. Ferguson S.E. Allen V.M. 2005 Heparin for pregnant women with acquired or inherited thrombophilias (review) The Cochrane Library q9
97. Wiener-Megnagi Z. Ben Shlomo I. Goldberg Y. Shalev E. 1998 Resistance to activated protein C and the leiden mutation: high prevalence in patients with abruptio placentae American Journal of Obstetrics and Gynecology 179 Pt 1 t-7
98. Wouters M.G. Boers G.H. Blom H.J Trijbels F.J. Thomas C.M. Borm G.F. 1993 Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss Fertility and Sterility 60 820 825
99. Yasuda M. Takakuwa K. Tokunaga A. Tanaka K. 1995 Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy Obstetrics and Gynecology 86 Pt 1 t-9
100. Younis J.S. Brenner B. Ohel G. Tal J. Lanir N. Ben Ami M. 2000 Activated protein C resistance and factor V Leiden mutation can be associated with first- as well as second-trimester recurrent pregnancy loss American Journal of Reproductive Immunology 43 31 35